Blueprint
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of
report (Date of earliest event reported): September 18, 2018
|
CORMEDIX
INC.
|
|
(Exact
Name of Registrant as Specified in Charter)
|
|
|
|
|
|
Delaware
|
001-34673
|
20-5894890
|
|
(State
or Other Jurisdictionof Incorporation)
|
(CommissionFile
Number)
|
(IRS
EmployerIdentification No.)
|
|
|
|
|
|
400
Connell Drive, Suite 5000, Berkeley Heights, NJ
|
07922
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant’s
Telephone Number, Including Area Code: (908) 517-9500
|
|
|
(Former
Name or Former Address, If Changed Since Last Report)
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for
complying with any
new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events.
We have established December 11, 2018 as the date of our 2018
annual meeting of stockholders and October 23, 2018 as the record
date for determining shareholders entitled to vote at the meeting.
The meeting date represents a change of more than 30 days from the
anniversary of the Company’s 2017 annual meeting of
shareholders.
The deadline for the receipt of any shareholder proposals for
inclusion in our proxy materials for the 2018 annual meeting of
stockholders is October 4, 2018. Any proposal submitted after the
above deadline will not be considered timely and will be excluded
from consideration at the 2018 annual meeting of stockholders.
Shareholder proposals and other items of business should be
directed to CorMedix Inc., 400 Connell Drive, Suite 5000, Berkeley
Heights, NJ, Attention: Corporate Secretary.
The time and location of the 2018 annual meeting of stockholders
will be as set forth in our proxy statement for the
meeting.
SIGNATURE
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
CORMEDIX
INC.
|
|
|
|
|
|
|
|
Date:
September 24, 2018 |
By:
|
/s/ Robert W.
Cook
|
|
|
|
Name:
|
Robert W.
Cook
|
|
|
|
Title:
|
Chief Financial
Officer
|
|